Christina S. Hassing - Publications

Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: January 03, 2026

Evaluating the Prognostic Role of the PAM50 Signature and Selected Immune-Related Signatures for Recurrence in Patients With T1abN0 Breast Cancer.

Journal: Clinical breast cancer

Published: March 05, 2024

Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study.

Journal: Breast cancer research and treatment

Published: September 08, 2022

Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study.

Journal: Breast cancer research and treatment

Published: July 04, 2022

Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: March 08, 2022

Reply to: Adequate use of radioactive seed localisation. Where we are?

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 13, 2018

Radioactive seed localisation of non-palpable lymph nodes - A feasibility study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: December 15, 2017

Radioactive seed localization of renal cell carcinoma in a patient with Von Hippel-Lindau disease.

Journal: Clinical case reports

Published: May 12, 2016